Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs WY✓SelectedUSD · WYGSK vs WY performance historyLatest closeAs of-2.71%09/08
Stock and ETF performance explorer

GSK vs WY

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+1,657.0%
WY return
+676.8%
Excess return
+980.2%
Maximum drawdown
-55.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioWYExcessAlpha
1D-2.7%-1.4%-1.3%-2.4%
7D-4.2%-2.1%-2.1%-3.7%
30D-7.5%-10.5%+3.0%-5.2%
3M-3.3%-4.9%+1.6%-2.4%
6M-9.3%-4.9%-4.4%-8.5%
YTD+1.6%-1.7%+3.3%+1.6%
1Y+25.5%-9.4%+34.9%+27.6%
3Y+49.3%-22.3%+71.6%+55.4%
5Y+46.7%-20.5%+67.2%+49.4%
10Y+76.8%+4.9%+71.9%+59.0%
All+1,657.0%+676.8%+980.2%+691.3%

Cumulative growth

Daily Returns

Daily percentage return beside WY.

Daily Out/Under-Performance

Portfolio return minus WY return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × WY return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded WY wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling